Volume 18, Number 6—June 2012
CME ACTIVITY - Research
Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France
Frédéric Bert
, Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
, Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
Table 3
Antimicrobial drug susceptibility, ERIC-2 PCR type, and β-lactamase gene content of the 39 clinical isolates of ESBL-producing Enterobacteriaceae identified, France, January 2001–April 2010*
| Species | Year of isolation | Susceptibility |
ERIC-2 PCR type | β-lactamase types† |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TZP | FOX | AMK | CIP | CTX-M-1 group | CTX-M-9 group | ESBL TEM | Non-ESBL TEM | ESBL SHV | Non-ESBL SHV | |||
| E. coli | 2003 | S | S | S | R | 1 | + | – | – | + | – | – |
| E. coli | 2004 | R | S | S | R | 2 | + | – | – | + | – | – |
| E. coli | 2004 | R | R | S | S | 3 | + | – | – | – | – | – |
| E. coli | 2007 | R | R | R | R | 4 | + | – | – | – | – | – |
| E. coli | 2007 | S | S | S | R | 5 | + | – | – | + | – | + |
| E. coli | 2008 | S | S | R | R | 6 | + | – | – | – | – | – |
| E. coli | 2008 | R | S | S | R | 7 | + | – | – | – | – | – |
| E. coli | 2008 | S | S | S | S | 8 | + | – | – | + | – | + |
| E. coli | 2009 | S | S | R | R | 9 | + | – | – | + | – | – |
| E. coli | 2009 | S | S | S | R | 10 | – | + | – | – | – | – |
| E. coli | 2009 | S | R | R | R | 9 | + | – | – | + | – | – |
| E. coli | 2009 | R | S | R | R | 11 | + | + | – | + | – | – |
| E. coli | 2009 | R | S | S | R | 4 | + | – | – | + | – | – |
| E. coli | 2010 | R | S | R | R | 12 | + | – | – | – | – | – |
| E. coli | 2010 | S | S | S | S | 13 | + | – | – | – | – | – |
| E. coli | 2010 | R | R | R | R | 14 | + | – | – | – | – | – |
| K. pneumoniae | 2008 | R | S | S | R | 15 | + | – | – | – | – | + |
| K. pneumoniae | 2008 | R | S | S | R | 16 | + | – | – | – | – | + |
| K. pneumoniae | 2010 | R | R | R | R | 17 | + | – | – | + | – | + |
| K. pneumoniae | 2010 | R | R | R | R | 17 | + | – | – | + | – | + |
| K. pneumoniae | 2010 | R | S | S | R | 15 | + | – | – | – | + | – |
| K. oxytoca | 2009 | R | R | R | R | 18 | – | – | – | – | + | – |
| K. oxytoca | 2009 | R | R | R | R | 18 | – | – | – | – | + | – |
| K. oxytoca | 2009 | R | R | R | R | 18 | + | – | – | + | – | – |
| C. koserii | 2006 | S | R | R | R | 19 | – | + | + | – | – | – |
| C. koserii | 2006 | S | R | R | R | 19 | – | + | + | – | – | – |
| E. cloacae | 2002 | R | R | R | R | 20 | – | – | – | + | - | – |
| E. cloacae | 2004 | R | R | R | R | 21 | + | – | – | + | + | – |
| E. cloacae | 2004 | R | R | S | R | 22 | – | – | – | – | + | – |
| E. cloacae | 2004 | R | R | I | R | 23 | – | – | – | – | + | – |
| E. cloacae | 2005 | R | R | R | R | 24 | – | – | – | + | – | – |
| E. cloacae | 2008 | S | R | R | R | 25 | + | – | – | + | + | – |
| E. cloacae | 2008 | S | R | R | R | 21 | – | – | – | + | + | – |
| E. cloacae | 2009 | R | R | S | R | 26 | + | – | – | + | – | – |
| E. cloacae | 2009 | R | R | S | R | 27 | + | – | – | – | – | – |
| E. cloacae | 2009 | S | R | R | R | 28 | + | – | – | – | + | – |
| E. cloacae | 2010 | S | R | R | R | 29 | – | – | – | + | + | – |
| E. aerogenes | 2002 | R | R | R | R | 30 | + | – | + | – | – | – |
| E. aerogenes | 2005 | R | R | R | R | 31 | + | + | – | + | + | – |
*ERIC-2, enterobacterial repetitive intergenic consensus sequence type 2; ESBL, extended-spectrum β-lactamase; TZP, piperacillin/tazobactam; FOX, cefoxitin; AMK, amikacin; CIP, ciprofloxacin; E. coli, Escherichia coli; S, susceptible; R, resistant; K. pneumoniae, Klebsiella pneumoniae; K. oxytoca, Klebsiella oxytoca; C. koserii, Citrobacter koserii; E. cloacae, Enterobacter cloacae; E. aerogenes, Enterobacter aerogenes.
†The types of β-lactamase were identified by the Check-KPC ESBL microarray system (Check-Points, Wageningen, the Netherlands).
Page created: May 17, 2012
Page updated: May 17, 2012
Page reviewed: May 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.